Détention brevets de la classe C40B 40/02

Brevets de cette classe: 594

Historique des publications depuis 10 ans

25
25
54
52
38
28
23
37
23
10
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Inscripta, Inc., FORMERLY Muse Biotechnology, Inc.
281
38
The Regents of the University of California
20494
20
Massachusetts Institute of Technology
10201
8
Yale University
2481
8
Genentech, Inc.
4063
7
Adimab, LLC
149
7
The Governing Council of The University of Toronto,
1540
7
48Hour Discovery Inc.
10
7
Affinity Biosciences Pty Ltd
10
6
National Research Council of Canada
1560
6
The University of British Columbia
1541
6
President and Fellows of Harvard College
6068
5
Adaptimmune Limited
165
5
CytomX Therapeutics, Inc.
230
5
The Governors of the University of Alberta
873
5
Immunocore Limited
230
5
Nantbio, Inc.
142
5
Centre National de La Recherche Scientifique
10855
4
The Board of Trustees of the Leland Stanford Junior University
6604
4
Takeda Pharmaceutical Company Limited
2728
4
Autres propriétaires 432